Feb 19, 2019

15 years of strategic collaboration between Grunenthal and TCG Lifesciences

The year 2018 marks the completion of 15 years of strategic collaboration between Grunenthal and TCG Lifesciences. This partnership started in the year 2003 with a simple fee-for-service custom synthesis project and gradually expanded into a sizeable FTE based collaborative working relationship covering a variety of services including Medicinal Chemistry, Process Development, Analytical Development, Library Synthesis, Scale-Up Synthesis as well as an integrated Drug Discovery mode across several therapeutic targets.
As a result, TCG Lifesciences has made a significant contribution to Grünenthal’s R&D activities through high quality, timely and cost effective delivery of new chemical entities across a broad range of drug discovery and development programs.
This exemplary and progressive journey of 15 years is built upon a strong trust-based relationship, effective teamwork and close communications between the scientific teams of both partners.